Walt Piskorski is a chemical engineer and manager with extensive experience in all aspects of commercializing drug development. Read more...
Chief Medical Officer
Alan F. Schatzberg, MD
Kenneth T. Norris, Jr., Professor
Dept. of Psychiatry and Behavioral Sciences
Stanford Univ. School of Medicine
Chief Scientific Officer
Stephen M. Stahl, MD, PhD
Adjunct Prof. of Psychiatry, Univ. of California San Diego
Honorary Visiting Sr. Fellow, Univ. of Cambridge, UK
Editor-in Chief, CNS Spectrums
Dir of Psychopharmacology Services & Sr. Academic Advisor,
CA Dept. of State Hospitals
Frank Bymaster has expertise in many areas of neuroscience and drug development for psychiatric diseases/disorders and has worked in these fields for over 45 years. Read more...
Dr. Aloke Dutta completed a MS degree in chemistry from Calcutta University and a Ph.D. from the Dept. of Chemistry at Ohio University. Read more...
Timothy Hsu, MD
Scientific Advisory Board
Aloke Dutta, Chair
Timothy Hsu MD is former Sr VP and Chief Medical Officer at Neurovance and at Euthymics Bioscience, where he directed the development of novel triple reuptake inhibitors (TRI) for both ADHD and MDD. Read more...
Maurizio Fava, MD
Director, Div. of Clinical Research of the MGH Research Institute
Executive Vice Chair, Dept. of Psychiatry
Executive Director, Clinical Trials Network and Institute (CTNI)
Massachusetts General Hospital (MGH)
Associate Dean for Clinical and Translational Research
Slater Family Professor of Psychiatry
Harvard Medical School
Aloke Dutta, PhD
Head of Scientific